These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7494183

  • 21. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S, Khandai M, Sharma A, Patra ChN, Patro VJ, Sen KK.
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [Abstract] [Full Text] [Related]

  • 22. Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.
    Taha EI, Shazly GA, Harisa GI, Barakat NS, Al-Enazi FK, Elbagory IM.
    Pak J Pharm Sci; 2015 Mar; 28(2):573-9. PubMed ID: 25730790
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
    Yan G, Li H, Zhang R, Ding D.
    Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L, Bruni R, Conte U.
    Int J Pharm; 2000 Feb 15; 195(1-2):229-38. PubMed ID: 10675700
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD, Kuhelj V, Vrečer F, Baumgartner S.
    Pharm Dev Technol; 2013 Feb 15; 18(2):343-7. PubMed ID: 21916601
    [Abstract] [Full Text] [Related]

  • 30. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
    Bravo SA, Lamas MC, Salomon CJ.
    Pharm Dev Technol; 2004 Feb 15; 9(1):75-83. PubMed ID: 15000468
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of polymer blends on release profiles of diclofenac sodium from matrices.
    Samani SM, Montaseri H, Kazemi A.
    Eur J Pharm Biopharm; 2003 May 15; 55(3):351-5. PubMed ID: 12754011
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of diclofenac sodium release from matrix pellets compressed into MUPS tablets.
    Ivić B, Ibrić S, Betz G, Djurić Z.
    Yakugaku Zasshi; 2009 Nov 15; 129(11):1375-84. PubMed ID: 19881210
    [Abstract] [Full Text] [Related]

  • 35. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
    Baluom M, Friedman M, Assaf P, Haj-Yehia AI, Rubinstein A.
    Pharm Res; 2000 Sep 15; 17(9):1071-6. PubMed ID: 11087038
    [Abstract] [Full Text] [Related]

  • 36. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M, Mishra B.
    AAPS PharmSciTech; 2004 Aug 20; 5(4):e71. PubMed ID: 15760068
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.
    Krögel I, Bodmeier R.
    J Control Release; 1999 Aug 27; 61(1-2):43-50. PubMed ID: 10469901
    [Abstract] [Full Text] [Related]

  • 40. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L, Rabisková M, Medvecká G.
    Ceska Slov Farm; 2003 Nov 27; 52(6):295-8. PubMed ID: 14661369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.